Publications by authors named "Yann Molin"

Claim this Profile
T
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.
Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade, Rocio Garcia-Carbonero, Olivier Bouché, Yann Molin

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03.
Olivier Trédan, Delphine Loirat, Sylvie Chabaud, Philippe Toussaint, Thierry Petit, Yann Molin

Breast· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohort.
Sylvain Manfredi, Marie Dior, Olivier Bouche, Emilie Barbier, Vincent Hautefeuille, Yann Molin

Cancer Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study.
Jean Marc Phelip, Jérôme Desrame, Julien Edeline, Emilie Barbier, Eric Terrebonne, Yann Molin

J Clin Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PALLIA-10, a screening tool to identify patients needing palliative care referral in comprehensive cancer centers: A prospective multicentric study (PREPA-10).
Yann Molin, Caroline Gallay, Julien Gautier, Audrey Lardy-Cleaud, Romaine Mayet

Cancer Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.
Jérôme Fayette, Yann Molin, Emilie Lavergne, Xavier Montbarbon, Séverine Racadot

Drug Des Devel Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumors.
Mélodie Carbonnaux, Yann Molin, Pierre-Jean Souquet, Arnaud Tantin, Catherine Lombard-Bohas

Invest New Drugs· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DCC constrains tumour progression via its dependence receptor activity.
Marie Castets, Laura Broutier, Yann Molin, Marie Brevet, Guillaume Chazot

Nature· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current chemotherapies for recurrent/metastatic head and neck cancer.
Yann Molin, Jérôme Fayette

Anticancer Drugs· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis